The UKAS-accredited certification body URS continues to certify GNH India, a company cited by the US Food and Drug Administration, and other national health services, for selling fake COVID-19 cures.

Click to enlarge

In 2022, Oxebridge filed a series of complaints against GNH India after the US FDA issued a public warning letter, accusing the company of fraudulently marketing Biocence eucalyptus products as being “99.99% effective” against COVID-19. The claims were deemed fraudulent by the FDA.

The management of GNH India fought Oxebridge, threatening legal action, and denying the accusations outright, despite their public website hosting a trove of marketing materials proving the FDA claim was accurate. The company was then cited by the Indian Food and Drug Administration, and forced to remove the products from its website.

Throughout the scandal, however, GNH India maintained its certification to ISO 9001 by URS’ Indian office. URS claimed to be investigating the matter, but a check of IAF Certsearch data as of May 6th, 2023 shows that GNH India is still fully-certified. (See image at right.)

GNH India repeatedly cited its certification by URS as a defense.

The ISO 9001 certificate issued by URS claims that GNH India is in full compliance with the quality management system standard, which would be technically impossible given their dogged insistence on selling potentially lethal, fake COVID-19 cures.

At no time during the discussions with Oxebidge did either URS or UKAS display any concern for public health, according to Oxebridge founder Christopher Paris. “They refused, repeatedly, to address the incredible risks that GNH was imposing on the public,” Paris said. “URS and UKAS had zero concern if people died because they bought these fake products instead of getting professional medical help.

The scandal again provides more evidence to support the theory that ISO certifications have become a “protection racket,” and that the certification bodies and accreditation bodies will provide legal cover to companies that pay for certification, even when those companies break the law.


ISO Benchmark

Why we report on these topics

Since 2000, Oxebridge has worked to improve ISO and related certification schemes by identifying problems and then proposing solutions. We report on issues affecting standards users because so few other news outlets do. Our belief is that in order to fix the problems in these schemes, we must first understand the nature and breadth of those problems. Our reporting aims to do just that. Elsewhere on the Oxebridge site you will find White Papers and other articles proposing ideas to correct these problems.